1376
X. Q. Xiong
(s, 4H, 4 × C≡CH), 4.65 (s, 8H, 4 × OCH2C≡CH), 4.97 (s, 4H,
2 × CH2O), 6.55–7.14 (m, 14H, H-Ar). δC 31.93 (2C, CH3),
42.60 (1C, C(CH3)2), 56.83 (4C, OCH2C≡CH), 70.57 (2C,
OCH2Ar), 76.68 (4C, C≡CH), 79.21 (4C, C≡CH), 102.54,
107.70, 115.10, 128.66, 140.76, 144.37, 157.36, 159.72 (C-Ar).
m/z (MALDI-TOF) 647.0 [M + Na]+, 663.0 [M + K]+.
Compound 7a: δH 0.99 (s, 12H, 4 × CH3), 1.60 (s, 6H,
2 × CH3), 3.12–3.34 (m, 24H, H-6, 10, 12, and –OH), 3.63–
3.71 (m, 24H, H-7, 8, and 11), 4.71 (s, 4H, H-14), 4.88 (s, 4H,
H-2), 5.14 (s, 8H, H-3), 5.86 (dd, 8H, H-5), 6.57–7.31 (m, 42H,
H-Ar), 8.19 (s, 4H, H-4), 8.37 (s, 4H, H-Ar). δC 17.31, 31.10,
37.74, 45.82, 46.22, 47.62, 48.20, 49.16, 49.66, 61.74, 62.09,
67.29, 69.80, 106.90, 114.26, 121.38, 124.10, 124.83, 125.72,
126.55, 126.92, 127.18, 127.34, 127.52, 127.89, 128.90, 131.23,
138.93, 139.17, 140.05, 141.89, 143.49, 143.61, 156.51, 159.59,
175.32, 176.54. m/z (MALDI-TOF) 2609.1 [M + Na]+.
One-Pot Synthesis of Dendritic Architectures
Compound
3
(0.50 g, 0.80 mmol), azide-functionalized
anthracene 4 (0.82 g, 3.50 mmol), and bis-MPA dendron 5a or
5b (6.40 mmol, 2.0 equiv.) were dissolved in nitrogen-purged
DMF (10 mL) in a Schlenk flask, CuBr (46.0 mg, 0.32 mmol,
0.1 equiv.) and PMDETA (55.4 mg, 0.32 mmol, 0.1 equiv.) were
added, and the reaction mixture was degassed by three freeze–
pump–thaw cycles and left under nitrogen and stirred at room
temperature for 12 h. The reaction mixture was then stirred at
110◦C for 3 h. When the reaction was completed, the mixture
was evaporated under high vacuum. The crude product obtained
was then dissolved in 5.0 mL of THF and passed through an
alumina column to remove the copper salt. The solution was
evaporated to give a crude product, which was purified by col-
umn chromatography (SiO2, DCM/PE, 1/3, v/v). The dendrimer
6a or 6b was isolated as a white solid (the yields were 73 and
65%, respectively).
Compound 6a: δH 1.13 (s, 12H, 4 × CH3), 1.33 (s, 12H,
4 × CH3), 1.37 (s, 12H, 4 × CH3), 1.62 (s, 6H, 2 × CH3), 3.14–
3.28 (m, 8H, H-10, 12), 3.37 (t, J 5.50, 8H, 4 × NCH2), 3.56
(d, J 11.80, 8H, H-8, 11), 3.61 (t, J 5.45, 8H, H-7), 4.10 (d, J
11.80, 8H, H-8, 11), 4.74 (d, J 2.90, 4H, H-14), 4.92 (s, 4H,
H-2), 5.16 (s, 8H, H-3), 5.86 (dd, 8H, H-5), 6.67–7.35 (m,
42H, H-Ar), 8.25 (s, 4H, H-4), 8.35 (s, 4H, H-Ar). δC 19.43,
23.53, 25.51, 26.50, 31.94, 38.09, 42.60, 46.66, 47.02, 48.40,
48.98, 49.93, 61.96, 62.88, 66.70, 66.75, 68.86, 70.59, 98.95,
107.55, 115.01, 122.20, 124.86, 125.65, 126.56, 127.08, 127.74,
127.96, 128.15, 128.36, 128.66, 139.71, 139.85, 140.85, 142.64,
144.33, 160.45, 174.72, 176.70, 177.04. m/z (MALDI-TOF)
2747.4 [M]+•, 2768.4 [M + Na]+.
Compound 7b: δH ((D6)DMSO) 1.02 (s, 24H, 8 × CH3), 1.16
(s, 12H, 4 × CH3), 1.57 (s, 6H, 2 × CH3), 3.24 (s, 8H, H-10, 12),
3.40–3.49 (m, 40H, H-7, 8, 11, and –OH), 4.10–4.30 (m, 40H,
H-7, 8, 11, 15, and –OH), 4.81 (s, 4H, H-14), 4.99 (s, 4H, H-2),
5.18 (s, 8H, H-3), 5.90 (dd, 8H, H-5), 6.73–7.85 (m, 42H, H-Ar),
8.28 (s, 4H, H-4), 8.53 (s, 4H, H-Ar). δC ((D6)DMSO) 17.30,
17.63, 36.89, 40.45, 45.34, 46.51, 46.70, 47.67, 48.18, 50.88,
61.65, 64.32, 65.32, 79.70, 114.69, 122.36, 124.69, 125.71,
126.44, 127.08, 127.25, 127.42, 127.59, 128.00, 139.68, 139.91,
141.24, 142.93, 143.05, 159.82, 172.57, 174.69, 176.48. m/z
(MALDI-TOF) 3538.0 [M + Na]+.
Accessory Publication
Scheme S1 of the synthesis of alkyne-modified compound 3,
Figs S1–S2 of the H and 13C NMR spectra of compound 3,
1
1
Fig. S3 of the H NMR spectrum of 6b, Fig. S4 of the 13C
NMR spectrum of 6a, Fig. S5 of the 13C NMR spectrum of
1
6b, Figs S6–S7 of the H and 13C NMR spectra of compound
4ꢀ, Figs S8–S9 of the UV/vis and fluorescence spectra of 4ꢀ
1
and 6b, Fig. S10 of the H NMR spectrum of 7b, Fig. S11 of
the partial 13C NMR spectra of 6a and 7a, Fig. S12 of the 13
C
NMR spectrum of 7b, Fig. S13 of the SEC traces of 3, 5a, 6a,
and 7a, and Fig. S14 of the MALDI-TOF MS spectrum of 7a
are available from the Journal’s website.
Acknowledgements
Financial support by the Special Foundation for Young Scientists of Fujian
Province, China (Grant No. 2008F3067) and the Scientific Research Starting
Foundation of Huaqiao University, China (Grant No. 08BS213) are greatly
acknowledged. The author is grateful to Professor Yongming Chen at CAS
for his useful discussions in this work and for help with GPC and NMR
characterization.
Compound 6b: δH 1.09 (s, 12H, 4 × CH3), 1.10 (s, 12H,
4 × CH3), 1.25 (s, 24H, 8 × CH3), 1.27 (s, 12H, 4 × CH3),
1.36 (s, 12H, 4 × CH3), 1.37 (s, 12H, 4 × CH3), 1.62 (s, 6H,
2 × CH3), 3.23 (d, 4H, J 8.48, H-10), 3.31–3.36 (m, 12H,
4 × NCH2, H-12), 3.56–3.60 (m, 24H, H-8, 11, 15, and 17),
4.08–4.27 (m, 32H, H-7, 8, 11, 15, and 17), 4.74 (d, J 2.68, 4H,
H-14), 4.91 (s, 4H, H-2), 5.15 (s, 8H, H-3), 5.90 (dd, 8H, H-5),
6.67–7.35 (m, 42H, H-Ar), 8.18 (s, 4H, H-4), 8.34 (s, 4H,
H-Ar). δC 12.30, 14.99, 15.19, 18.38, 19.35, 19.40, 20.31, 21.30,
22.63, 22.69, 23.50, 23.51, 26.20, 29.92, 32.45, 42.21, 42.89,
42.92, 46.67, 47.59, 48.55, 49.02, 62.82, 62.84, 66.09, 66.81,
98.94, 115.00, 122.29, 124.83, 125.63, 126.50, 127.16, 127.66,
127.89, 128.07, 128.27, 128.64, 135.12, 139.86, 139.99, 140.97,
142.70, 144.22, 157.39, 160.51, 172.96, 174.45, 176.94, 177.20.
m/z (MALDI-TOF) 3859.2 [M + Na]+, 3875.2 [M + K]+.
References
[1] F. Vögtle, S. Gestermann, R. Hesse, H. Schwierz, B. Windisch, Prog.
Polym. Sci. 2000, 25, 987. doi:10.1016/S0079-6700(00)00017-4
[2] G. R. Newkome, C. N. Moorefield, F. Vögtle, Dendrimers and
Dendrons, Concepts, Syntheses, Applications 2001 (Wiley-VCH:
Weinheim).
[3] J. M. J. Fréchet, D. A. Tomalia, Dendrimers and Other Dendritic
Polymers 2002 (Wiley: New York, NY).
[4] A. Adronov, J. M. J. Fréchet, Chem. Commun. 2000, 1701.
doi:10.1039/B005993P
[5] S. C. Lo, P. L. Burn, Chem. Rev. 2007, 107, 1097. doi:10.1021/
CR050136L
[6] S. Svenson, D. A. Tomalia, Adv. Drug Deliv. Rev. 2005, 57, 2106.
doi:10.1016/J.ADDR.2005.09.018
[7] M. Najlah, A. D’Emanuele, Curr. Opin. Pharmacol. 2006, 6, 522.
doi:10.1016/J.COPH.2006.05.004
[8] A. V. Ambade, E. N. Savariar, S. Thayumanavan, Mol. Pharm. 2005,
2, 264. doi:10.1021/MP050020D
General Procedure for the Hydrolysis of 6a and 6b
The protected dendrimer 6a or 6b (0.18 mmol) was dissolved in a
mixture ofTHF and MeOH (3/1, v/v, 10 mL) and three teaspoons
of Dowex H+ resin were added, the reaction mixture was stirred
for 3 h at room temperature.When the reaction was complete, the
Dowex H+ resin was filtered off in a glass filter and carefully
washed with THF. The solution was evaporated to give a pale
solid 7a or 7b (the yields were 91 and 90%, respectively).
[9] M. F. Neerman, H.T. Chen,A. R. Parrish, E. E. Simanek, Mol. Pharm.
2004, 1, 390. doi:10.1021/MP049957P